Per Hydbring相关文献与解析，生知库 | 链接生命科学的每一步

Xun Zhou # ,Eva Berenger # ,Yong Shi # ,Vera Shirokova ,Elena Kochetkova ,Tina Becirovic ,Boxi Zhang ,Vitaliy O Kaminskyy ,Yashar Esmaeilian ,Kayoko Hosaka ,Cecilia Lindskog ,Per Hydbring ,Simon Ekman ,Yihai Cao ,Maria Genander ,Marcin Iwanicki ,Erik Norberg ,Helin Vakifahmetoglu-Norberg

肿瘤

Autophagy

自噬

发表日期：2025

文献求助收藏

Construction and validation of a prognostic model based on oxidative stress-related genes in non-small cell lung cancer (NSCLC): predicting patient outcomes and therapy responses

基于非小细胞肺癌（NSCLC）氧化应激相关基因的预后模型的构建和验证：预测患者结果和治疗反应

期刊:Translational Lung Cancer Research

影响因子:4

doi:10.21037/tlcr-24-888

Dongfeng Sun, Jie Lu, Wenhua Zhao, Xiaozheng Chen, Changyan Xiao, Feng Hua, Per Hydbring, Esteban C Gabazza, Alfredo Tartarone, Xiaoming Zhao, Wenfeng Yang

Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer

miR-494-3p 表达升高与 EGFR T790M 阳性非小细胞肺癌对奥希替尼的耐药性有关

期刊:Translational Lung Cancer Research

影响因子:4

doi:10.21037/tlcr-21-955

Dominika Kaźmierczak #, Inger Johanne Zwicky Eide #, Radosveta Gencheva, Yi Lai, Rolf Lewensohn, Georgios Tsakonas, Oscar Grundberg, Luigi de Petris, Marc McGowan, Odd Terje Brustugun #, Simon Ekman #, Per Hydbring #

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

MYCMI-7：一种小型 MYC 结合化合物，以 MYC 依赖的方式抑制 MYC：MAX 相互作用和肿瘤生长

期刊:Cancer Research Communications

影响因子:2

doi:10.1158/2767-9764.CRC-21-0019

Alina Castell, Qinzi Yan, Karin Fawkner, Wesam Bazzar, Fan Zhang, Malin Wickström, Mohammad Alzrigat, Marcela Franco, Cecilia Krona, Donald P Cameron, Cecilia Dyberg, Thale Kristin Olsen, Vasiliki Verschut, Linnéa Schmidt, Sheryl Y Lim, Loay Mahmoud, Per Hydbring, Sören Lehmann, Laura Baranello, Sve

肿瘤

发表日期：2022

文献求助收藏

Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer

Ras 相关蛋白 Rab-32 和血小板反应蛋白 1 通过激活非小细胞肺癌中的粘着斑激酶赋予对 EGFR 酪氨酸激酶抑制剂奥希替尼的耐药性

期刊:Cancers

影响因子:

doi:10.3390/cancers14143430

Zeinab Kosibaty, Odd Terje Brustugun, Inger Johanne Zwicky Eide, Georgios Tsakonas, Oscar Grundberg, Luigi De Petris, Marc McGowan, Per Hydbring, Simon Ekman

Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage

对非小细胞肺癌患者细针抽吸物的多重免疫蛋白分析揭示了与 PD-L1 表达和肿瘤分期相关的特征

期刊:Molecular Oncology

影响因子:5

doi:10.1002/1878-0261.12952

Bo Franzén, Kristina Viktorsson, Caroline Kamali, Eva Darai-Ramqvist, Vitali Grozman, Vasiliki Arapi, Petra Hååg, Vitaliy O Kaminskyy, Per Hydbring, Lena Kanter, Sven Nyrén, Simon Ekman, Luigi De Petris, Rolf Lewensohn

Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence

CDK2 的药理失活可通过诱导细胞衰老来抑制体内 MYC/BCL-XL 驱动的白血病

期刊:Cell Cycle

影响因子:3.4

doi:10.1080/15384101.2020.1855740

Wesam Bazzar, Matteo Bocci, Eduar Hejll, Vedrana Högqvist Tabor, Per Hydbring, Alf Grandien, Mohammad Alzrigat, Lars-Gunnar Larsson

A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation

选择性高亲和力 MYC 结合化合物可抑制 MYC:MAX 相互作用和 MYC 依赖性肿瘤细胞增殖

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-018-28107-4

Alina Castell, Qinzi Yan, Karin Fawkner, Per Hydbring, Fan Zhang, Vasiliki Verschut, Marcela Franco, Siti Mariam Zakaria, Wesam Bazzar, Jacob Goodwin, Giovanna Zinzalla, Lars-Gunnar Larsson

Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers

以细胞周期为靶点的微小RNA作为难治性癌症的治疗工具

期刊:Cancer Cell

影响因子:48.8

doi:10.1016/j.ccell.2017.03.004

Per Hydbring, Yinan Wang, Anne Fassl, Xiaoting Li, Veronica Matia, Tobias Otto, Yoon Jong Choi, Katharine E Sweeney, Jan M Suski, Hao Yin, Roman L Bogorad, Shom Goel, Haluk Yuzugullu, Kevin J Kauffman, Junghoon Yang, Chong Jin, Yingxiang Li, Davide Floris, Richard Swanson, Kimmie Ng, Ewa Sicinska, L

D-cyclins repress apoptosis in hematopoietic cells by controlling death receptor Fas and its ligand FasL

D-细胞周期蛋白通过控制死亡受体 Fas 及其配体 FasL 抑制造血细胞凋亡

期刊:Developmental Cell

影响因子:10.7

doi:10.1016/j.devcel.2014.06.015

Yoon Jong Choi, Borja Saez, Lars Anders, Per Hydbring, Joanna Stefano, Nickolas A Bacon, Colleen Cook, Ilona Kalaszczynska, Sabina Signoretti, Richard A Young, David T Scadden, Piotr Sicinski

Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors

分子伴侣介导的自噬调控间质肿瘤的转移状态

Construction and validation of a prognostic model based on oxidative stress-related genes in non-small cell lung cancer (NSCLC): predicting patient outcomes and therapy responses

基于非小细胞肺癌（NSCLC）氧化应激相关基因的预后模型的构建和验证：预测患者结果和治疗反应

Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer

miR-494-3p 表达升高与 EGFR T790M 阳性非小细胞肺癌对奥希替尼的耐药性有关

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

MYCMI-7：一种小型 MYC 结合化合物，以 MYC 依赖的方式抑制 MYC：MAX 相互作用和肿瘤生长

Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer

Ras 相关蛋白 Rab-32 和血小板反应蛋白 1 通过激活非小细胞肺癌中的粘着斑激酶赋予对 EGFR 酪氨酸激酶抑制剂奥希替尼的耐药性

Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage

对非小细胞肺癌患者细针抽吸物的多重免疫蛋白分析揭示了与 PD-L1 表达和肿瘤分期相关的特征

Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence

CDK2 的药理失活可通过诱导细胞衰老来抑制体内 MYC/BCL-XL 驱动的白血病

A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation

选择性高亲和力 MYC 结合化合物可抑制 MYC:MAX 相互作用和 MYC 依赖性肿瘤细胞增殖

Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers

以细胞周期为靶点的微小RNA作为难治性癌症的治疗工具

D-cyclins repress apoptosis in hematopoietic cells by controlling death receptor Fas and its ligand FasL

D-细胞周期蛋白通过控制死亡受体 Fas 及其配体 FasL 抑制造血细胞凋亡